John F. Cannon is chair of Stradling's Securities Litigation and Enforcement practice group and a member of the firm's Board of Directors. He is the former chair of the Litigation department and a former Executive Committee member.
Represented Ansun Biopharma, Inc. in a Rights Offering. Ansun Biopharma is a clinical stage biopharmaceutical company that focuses on developing unique host-directed anti-viral therapies for respiratory viruses. *